biotech / news / / Benzinga
Moderna said it is conducting early-stage research into vaccines targeting hantaviruses.
Moderna is conducting early-stage research into mRNA vaccines targeting hantaviruses with US Army collaboration.
KEY POINTS
- In September 2024, Moderna began full-scale mRNA hantavirus vaccine development with Korea University's VIC-K.
- WHO has linked at least six confirmed hantavirus cases and three deaths to a cruise ship outbreak.
- Novavax reported $139.51 million in quarterly sales, significantly beating the $78.32 million estimate.
COMPANIES
Summarized by Newsio from Benzinga. How we summarize →